The AI industry is constantly churning out news, like major acquisitions, indie developer successes, public outcry, and existentially dangerous contract negotiations.

ImmunityBio's Anktiva drives revenue surge and new approvals, as U.S. uptake and global launches set up a pivotal 2026.

Amid the Trump administration's crackdown on fraud within Medicaid, a congressional committee is setting its sights on Oregon -- demanding information about the Oregon Health Plan and cases of waste, ...